Calithera Biosciences, Inc.
Treatment of lung cancer with inhibitors of glutaminase
Last updated:
Abstract:
The invention relates to methods of treating lung cancer using glutaminase inhibitors. In particular, results demonstrate that lung cancers characterized by an EGFR or KRAS mutation are treated by glutaminase inhibitors.
Status:
Grant
Type:
Utility
Filling date:
6 Apr 2016
Issue date:
15 Oct 2019